Ambu Q4 2013/14 Earnings Results Presentation

Ambu presents Q4 2013/14 financial results and FY 2014/15 guidance, highlighting 11% organic growth and strong performance in key product lines including aScope 3 and laryngeal masks. The company reports 36% EBIT increase with an EBIT margin of 18.1% and improving gross margins as planned.